News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
InvestorsHub90d agobullish
AbCellera shares surge 22% after ABCL635 delivers positive Phase 2 resultsBarrons.com90d agoneutral
This Biotech’s Drug Could Treat Hot Flashes. The Stock Is Up 32% on Good News.Stocktwits90d agoneutral
ABCL Stock Has Rallied 100% This Year - Now All Eyes Are On AbCellera’s Menopause Drug DataGuruFocus.com94d agoneutral
AbCellera Biologics Inc (ABCL) (Q2 2026) Earnings Call Highlights: Strong Pipeline Progress and ...Simply Wall St.102d agoneutral
Vertex Pharmaceuticals (VRTX) Expands Its Pipeline Reach, Is The Stock Fully Valued?Insider Monkey130d agoneutral
Is AbCellera Biologics (ABCL) One of the Best Stocks with Biggest Upside?Stocktwits132d agobullish
Why Did SLS, MRNA, ABCL Stocks Surge To 52-Week Highs Last Week?Simply Wall St.137d agobearish
Jazz Pharmaceuticals (JAZZ) Expands AbCellera Tie Up As Zepzelca Trial Misses GoalInsider Monkey138d agoneutral
Jazz Pharmaceuticals and AbCellera Biologics Inc. (ABCL) Announce CollaborationInvestorsHub144d agoneutral
Jazz Pharmaceuticals and AbCellera Partner on Antibody Programs for Solid TumorsSimply Wall St.154d agoneutral
A Look At AbCellera Biologics (ABCL) Valuation After ABCL635 Progress And Strong Q1 ResultsSimply Wall St.155d agoneutral
AbCellera’s Shift To Proprietary Drugs Puts ABCL635 And Governance In FocusMarketBeat157d agoneutral
AbCellera Biologics Bets on Hot Flash Antibody as Pipeline Pivot Gains SteamSimply Wall St.168d agoneutral
Does AbCellera (ABCL) Have a Clear Path From ABCL635 Data to a Durable Business Model?Insider Monkey170d agobullish
Here’s Why AbCellera (ABCL) is Among the 10 Best Penny Stocks to Buy for Long Term